Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Ferrara

Showing results (11-20 of 313) with videos related to

Pageof 32
Sort By:
Inflammopharmacology|May 1, 2021
Brief review of the mRNA vaccines COVID-19Antonio Vitiello, Francesco Ferrara
Wiener Klinische Wochenschrift|April 20, 2021
Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patientsAntonio Vitiello, Francesco Ferrara
Asian Journal of Pharmaceutical Sciences|December 1, 2021
Commentary of the mRNA vaccines COVID-19Antonio Vitiello, Francesco Ferrara
Respiratory Medicine|February 7, 2021
Colchicine and SARS-CoV-2: Management of the hyperinflammatory stateAntonio Vitiello, Francesco Ferrara
Cardiovascular Drugs and Therapy|August 30, 2021
Low Molecular Weight Heparin, Anti-inflammatory/Immunoregulatory and Antiviral Effects, a Short UpdateAntonio Vitiello, Francesco Ferrara
Discovery Medicine|February 17, 2021
Scientific and pharmacological rationale for the treatment of cardiac damage caused by COVID-19Francesco Ferrara, Antonio Vitiello
Cardiovascular Toxicology|July 13, 2021
Plausible Positive Effects of Statins in COVID-19 PatientAntonio Vitiello, Francesco Ferrara
European Journal of Pharmacology|July 18, 2020
Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?Antonio Vitiello, Francesco Ferrara
The Journal of Trauma and Acute Care Surgery|April 2, 2021
Reply to: "A multifaceted virus. Nonreducible and strangulated effects of COVID-19"Francesco Ferrara, Stefano Rausei
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|November 18, 2021
Risk of drug-induced cardiac arrhythmia during COVID-19 therapeutic treatmentAntonio Vitiello, Francesco Ferrara
Pageof 32

Showing results (11-20 of 313) with videos related to

Sort By:
Pageof 32
Inflammopharmacology|May 1, 2021
Brief review of the mRNA vaccines COVID-19Antonio Vitiello, Francesco Ferrara
Wiener Klinische Wochenschrift|April 20, 2021
Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patientsAntonio Vitiello, Francesco Ferrara
Asian Journal of Pharmaceutical Sciences|December 1, 2021
Commentary of the mRNA vaccines COVID-19Antonio Vitiello, Francesco Ferrara
Respiratory Medicine|February 7, 2021
Colchicine and SARS-CoV-2: Management of the hyperinflammatory stateAntonio Vitiello, Francesco Ferrara
Cardiovascular Drugs and Therapy|August 30, 2021
Low Molecular Weight Heparin, Anti-inflammatory/Immunoregulatory and Antiviral Effects, a Short UpdateAntonio Vitiello, Francesco Ferrara
Discovery Medicine|February 17, 2021
Scientific and pharmacological rationale for the treatment of cardiac damage caused by COVID-19Francesco Ferrara, Antonio Vitiello
Cardiovascular Toxicology|July 13, 2021
Plausible Positive Effects of Statins in COVID-19 PatientAntonio Vitiello, Francesco Ferrara
European Journal of Pharmacology|July 18, 2020
Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?Antonio Vitiello, Francesco Ferrara
The Journal of Trauma and Acute Care Surgery|April 2, 2021
Reply to: "A multifaceted virus. Nonreducible and strangulated effects of COVID-19"Francesco Ferrara, Stefano Rausei
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|November 18, 2021
Risk of drug-induced cardiac arrhythmia during COVID-19 therapeutic treatmentAntonio Vitiello, Francesco Ferrara
Pageof 32